MAM
McCain Foods appoints Madison Media as its media AoR
MUMBAI: McCain Foods India, the Indian subsidiary of McCain Foods Canada, has appointed Madison Media as its new media Agency on Record (AoR).
Madison Media will handle traditional media planning and buying for McCain along with the larger mandate on digital, display, social, video and mobile platforms.
Madison Media group CEO Gautam Kiyawat said, “McCain as a brand has tremendous potential in the Indian market and I am excited to have them onboard as our client and we are confident of helping them achieve their rightful dominant share”.
McCain Foods India MD Vikas Mittal said, “McCain brand is driving growth of frozen snacks in India. In pursuance, we have a line-up of new business strategies and accompanying communication initiatives. Today, we are looking at increasing our media presence across all touch points.”
“We wanted to take on board an agency that complimented our brand communication strategies. We are happy to announce the appointment of ‘Madison Media’ and we look forward to create a more distinct market space for McCain,” McCain Foods India general manager-marketing Gunjan Pandey added.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
